C-h Ohlmann

Kuno Fischer Str. 8
Berlin, BE 14057, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.

DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.

Journal: Trials

Published: October 15, 2022

Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma

Algorithms for systemic therapy of prostate cancer, transitional cell carcinoma and renal cell carcinoma

Journal: Der Urologe. Ausg. A

Published: April 18, 2020

Title Not Found

Title Not Found

Journal: Aktuelle Urologie

Published: July 26, 2019

Title Not Found

Title Not Found

Journal: Aktuelle Urologie

Published: August 08, 2018

Title Not Found

Title Not Found

Journal: Aktuelle Urologie

Published: February 02, 2018

Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-up.

Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-up.

Journal: PloS one

Published: January 11, 2018

First line therapy for locally advanced or metastatic urothelial cancer : A randomized double blind phase III multicenter study on adjuvant nivolumab therapy versus placebo in patients with invasive high-risk urothelial cancer (CheckMate 274)-AB 58/17 of the AUO

First line therapy for locally advanced or metastatic urothelial cancer : A randomized double blind phase III multicenter study on adjuvant nivolumab therapy versus placebo in patients with invasive high-risk urothelial cancer (CheckMate 274)-AB 58/17 of the AUO

Journal: Der Urologe. Ausg. A

Published: August 06, 2017

Metastatic prostate cancer : Update: position paper for the use of chemotherapy

Metastatic prostate cancer : Update: position paper for the use of chemotherapy

Journal: Der Urologe. Ausg. A

Published: July 12, 2017

First-line therapy for locally advanced or metastatic urothelial carcinoma : A randomized, controlled phase III trial comparing pembrolizumab with or without platinum-based combination chemotherapy and chemotherapy only in patients with advanced or metastatic urothelial carcinoma (keynote 361-AB 54/16 of the AUO)

First-line therapy for locally advanced or metastatic urothelial carcinoma : A randomized, controlled phase III trial comparing pembrolizumab with or without platinum-based combination chemotherapy and chemotherapy only in patients with advanced or metastatic urothelial carcinoma (keynote 361-AB 54/16 of the AUO)

Journal: Der Urologe. Ausg. A

Published: March 29, 2017

Follow-up of urological tumor treatment

Follow-up of urological tumor treatment

Journal: Der Urologe. Ausg. A

Published: August 07, 2015

Epigenetic regulation of urological tumors. Importance for prognosis and metastasis

Epigenetic regulation of urological tumors. Importance for prognosis and metastasis

Journal: Der Urologe. Ausg. A

Published: June 04, 2015

Nephron-sparing surgery 2012

Nephron-sparing surgery 2012

Journal: Aktuelle Urologie

Published: December 01, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026